iShares Neuroscience and Healthcare ETF (IBRN) is a iShares ETF with a 0.47% expense ratio, 80 holdings and $6.3MM in net assets. Largest sector: Healthcare (99%).
Fee
0.47%
expense ratio
Net assets
$6.3MM
Launched
Aug 24, 2022
Holdings
80
as of Oct 22, 2026
Top 10 weight
42.0%
largest ten holdings
Largest sector
Healthcare
99.0%
Yield
30-day SEC -0.14% · TTM 0.96%
as of Sep 30, 2026
Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Net Index
IBRN's holdings are as of Oct 22, 2026.
Healthcare
99.0%
Technology
1.1%
1
BIIB
BIOGEN
5.58%
2
ALKS
Alkermes
4.65%
3
EWTX
Edgewise Therapeutics
4.50%
4
NBIX
Neurocrine Biosciences
4.47%
5
PTCT
PTC Therapeutics
4.41%
6
ARGX
ARGENX
4.12%
7
SRRK
Scholar Rock Holding
3.68%
8
PRAX
Praxis Precision Medicines
3.57%
9
ACAD
ACADIA Pharmaceuticals
3.52%
10
DNTH
Dianthus Therapeutics
3.52%
11
SUPN
Supernus Pharmaceuticals
3.51%
12
326030
SK Biopharmaceuticals Ltd
3.39%
13
HLUN B
H. LUNDBECK CLASS B
3.17%
14
DYN
Dyne Therapeutics
3.15%
15
XENE
XENON PHARMACEUTICALS
2.96%
16
AXGN
Axogen
2.94%
17
BHVN
Biohaven Ltd
2.89%
18
SRPT
Sarepta Therapeutics
2.81%
19
NEU
NEUREN PHARMACEUTICALS
2.34%
20
BIOA B
BIOARCTIC CLASS B
1.99%
21
TSHA
Taysha Gene Therapies
1.62%
22
LBRX
LB Pharmaceuticals
1.59%
23
IDIA
IDORSIA LTD
1.48%
24
4588
ONCOLYS BIOPHARMA
1.40%
25
IART
Integra LifeSciences Holdings
1.25%
1–25 of 80